Register
Login
HOME
CHEMICAL
CHEMISTS
Q&A
USER CENTER
please select
Chemical
Chemists
Reference
Structured
search
Cyclohexanone, 3-ethyl-, (3R)-
Collect
BASIC PARAMETERS
Find an error
CAS: 74006-74-9
MF: C8H14O
MW: 126.19616
Synonyms: Cyclohexanone, 3-ethyl-, (3R)-
Supply Source
I can Supply this
REPORT BY
Walter Leitner
Institut für Technische und Makromolekulare Chemie
follow
Sabine Laschat
Institut für Organische Chemie der Universit?t Stuttgart
follow
Hans-Guenther Schmalz
University of Cologne
follow
TARTROL-derived chiral phosphine–phosphite ligands and their performance in enantioselective Cu-catalyzed 1,4-addition reactions
Co-reporter:
Mehmet Dindaroğlu, Sema Akyol, Hamza Şimşir, Jörg-Martin Neudörfl, Anthony Burke, Hans-Günther Schmalz
pp:
657-662
Publication Date(Web):
15 June 2013
DOI:
10.1016/j.tetasy.2013.04.008
By using (R,R,R,R)-2,3-dimethoxy-2,3-dimethyl-1,4-dioxane-5,6-bis-diphenylmethanol (TARTROL) as a chiral building block, a set of six modular phosphine–phosphite ligands (with a 1,2-phenylene backbone) were synthesized and evaluated in the Cu-catalyzed asymmetric 1,4-addition of Grignard reagents to cyclohexenone. Ligands with bulky substituents at the ortho- and para-positions to the chiral phosphite moiety were found to be the most selective affording the 1,4-addition products with enantioselectivities of up to 84% ee.
(2R,3R,5R,6R)-5,6-Dimethoxy-5,6-dimethyl-1,4-dioxane-2,3-dicarboxylic acid dimethyl esterC12H20O8
[α]58920=-140.6 (c 1.0, CHCl3),
[α]54620=-166.0 (c 1.0, CHCl3),
[α]40520=-324.7 (c 1.0, CHCl3),
[α]36520=-413.8 (c 1.0, CHCl3).Absolute configuration: (2R,3R,5R,6R)
(2R,3R,5R,6R)-2,3-Bis(hydroxydiphenylmethyl)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxaneC34H36O6
[α]58920=+50.6 (c 1.0, CHCl3),
[α]54620=+62.0 (c 1.0, CHCl3),
[α]40520=+154.1 (c 1.0, CHCl3),
[α]36520=+226.0 (c 1.0, CHCl3)Absolute configuration: (2R,3R,5R,6R)
(2R,3R,4aR,9aR)-7-(2,4-Di-tert-butyl-6-diphenyl-phosphino-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC60H64O7P2
[α]58920=+125.7 (c 0.5, CHCl3),
[α]54620=+153.5 (c 0.5, CHCl3),
[α]40520=+450.2 (c 0.5, CHCl3),
[α]36520=+764.0 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-Diphenylphosphino-4,6-di-tert-pentyl-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC62H68O7P2
[α]58920=+79.5 (c 0.5, CHCl3),
[α]54620=+99.8 (c 0.5, CHCl3),
[α]40520=+296.5 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-Diphenylphosphino-6-tert-pentyl-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC57H58O7P2
[α]58920=+137.1 (c 0.5, CHCl3),
[α]54620=+169.0 (c 0.5, CHCl3),
[α]40520=+470.0 (c 0.5, CHCl3),
[α]36520=+777.0 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-tert-Butyl-6-diphenylphosphino-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC56H56O7P2
[α]58920=+189.3 (c 0.5, CHCl3),
[α]54620=+230.7 (c 0.5, CHCl3),
[α]40520=+650.9 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(3-Diphenylphosphino-biphenyl-2-yloxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC58H52O7P2
[α]58920=+219.1 (c 0.5, CHCl3),
[α]54620=+269.4 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-Diphenylphosphino-6-methyl-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC53H50O7P2
[α]58920=+113.3 (c 0.5, CHCl3),
[α]54620+138.5 (c 0.5, CHCl3),
[α]40520= +375.1 (c 0.5, CHCl3),
[α]36520= +598.2 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
Simon Woodward
The University of Nottingham
follow
Paul G. Pringle
University of Bristol
follow
Zhou Zhongyuan
Hong Kong Polytechnic University
follow
Kenso Soai
Tokyo University of Science
follow
Satoshi Sakaguchi
Kansai University
follow
(2R,3R,5R,6R)-5,6-Dimethoxy-5,6-dimethyl-1,4-dioxane-2,3-dicarboxylic acid dimethyl esterC12H20O8
[α]58920=-140.6 (c 1.0, CHCl3), 
[α]54620=-166.0 (c 1.0, CHCl3), 
[α]40520=-324.7 (c 1.0, CHCl3), 
[α]36520=-413.8 (c 1.0, CHCl3).Absolute configuration: (2R,3R,5R,6R)
(2R,3R,5R,6R)-2,3-Bis(hydroxydiphenylmethyl)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxaneC34H36O6
[α]58920=+50.6 (c 1.0, CHCl3), 
[α]54620=+62.0 (c 1.0, CHCl3), 
[α]40520=+154.1 (c 1.0, CHCl3), 
[α]36520=+226.0 (c 1.0, CHCl3)Absolute configuration: (2R,3R,5R,6R)
(2R,3R,4aR,9aR)-7-(2,4-Di-tert-butyl-6-diphenyl-phosphino-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC60H64O7P2
[α]58920=+125.7 (c 0.5, CHCl3), 
[α]54620=+153.5 (c 0.5, CHCl3), 
[α]40520=+450.2 (c 0.5, CHCl3), 
[α]36520=+764.0 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-Diphenylphosphino-4,6-di-tert-pentyl-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC62H68O7P2
[α]58920=+79.5 (c 0.5, CHCl3), 
[α]54620=+99.8 (c 0.5, CHCl3), 
[α]40520=+296.5 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-Diphenylphosphino-6-tert-pentyl-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC57H58O7P2
[α]58920=+137.1 (c 0.5, CHCl3), 
[α]54620=+169.0 (c 0.5, CHCl3), 
[α]40520=+470.0 (c 0.5, CHCl3), 
[α]36520=+777.0 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-tert-Butyl-6-diphenylphosphino-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC56H56O7P2
[α]58920=+189.3 (c 0.5, CHCl3), 
[α]54620=+230.7 (c 0.5, CHCl3), 
[α]40520=+650.9 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(3-Diphenylphosphino-biphenyl-2-yloxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC58H52O7P2
[α]58920=+219.1 (c 0.5, CHCl3), 
[α]54620=+269.4 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)
(2R,3R,4aR,9aR)-7-(2-Diphenylphosphino-6-methyl-phenoxy)-2,3-dimethoxy-2,3-dimethyl-5,5,9,9-tetraphenyl-hexahydro-[1,4]dioxino[2,3-e][1,3,2]-dioxaphosphepineC53H50O7P2
[α]58920=+113.3 (c 0.5, CHCl3), 
[α]54620+138.5 (c 0.5, CHCl3), 
[α]40520= +375.1 (c 0.5, CHCl3), 
[α]36520= +598.2 (c 0.5, CHCl3)Absolute configuration: (2R,3R,4aR,9aR)